CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized, Double-blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observational Period

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00051636
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:20.130268+00:00
Published At: 2012-05-07T00:00:00+00:00
Record Updated At: 2012-05-15
Results Posted At: 2012-05-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Paget\u0027s Disease of Bone"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-05-15"
protocolSection.identificationModule.nctId: "NCT00051636"
protocolSection.identificationModule.officialTitle: "Randomized, Double-blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget\u0027s Disease of Bone Using Risedronate as a Comparator, Including an Extended Observational Period"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2012-05-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.